Microba Life Sciences (ASX:MAP) Total Stockholders Equity: A$30.18 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Microba Life Sciences Total Stockholders Equity?

Microba Life Sciences ASX:MAP Total Stockholders Equity is A$30.18 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Microba Life Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2025 was A$30.18 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Microba Life Sciences's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Microba Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.08.

Microba Life Sciences  (ASX:MAP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Microba Life Sciences's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(30.18-0)/608.963
=0.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Microba Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.524 + 1.013) / 30.18
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Total Stockholders Equity Related Terms

Microba Life Sciences Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Total Stockholders Equity Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Total Stockholders Equity
33.54 38.57 41.22 32.49

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 49.25 41.22 35.69 32.49 30.18
What does a Total Stockholders Equity of A$30.18 Mil mean?
Microba Life Sciences (ASX:MAP) has a Total Stockholders Equity of A$30.18 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Microba Life Sciences and its competitors.
Is Microba Life Sciences' Total Stockholders Equity too high?
Microba Life Sciences' current Total Stockholders Equity is A$30.18 Mil.
How does Microba Life Sciences' Total Stockholders Equity compare to TMO and DHR?
Microba Life Sciences' Total Stockholders Equity of A$30.18 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Microba Life Sciences and its competitors. Microba Life Sciences's current Total Stockholders Equity is A$30.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.24, compared to a current price of A$0.05 — trading 80% below its estimated fair value. The current Total Stockholders Equity is A$30.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current Total Stockholders Equity is A$30.18 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microba Life Sciences Business Description

Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.